TERAPIA

RHINXYL HA CHILDREN 0.5MG/ML NASAL SPRAY

You're reading an Auto-translation.

Composition.

The active substance is xylometazoline hydrochloride. 1 ml of RHINXYL HA 0.5 mg/ml nasal spray, solution contains 0.5 mg xylometazoline hydrochloride. One spray (70 µl) contains 0.035 mg xylometazoline hydrochloride. The excipients are purified sea water, potassium dihydrogen phosphate, sodium hyaluronate, purified water.

Therapeutic indications.

RHINXYL nasal spray, solution belongs to a group of medicines for the treatment of nasal diseases, called sympathomimetics. It contains xylometazoline hydrochloride, which helps constrict blood capillaries in the nose, thereby reducing nasal mucosal congestion.

RHINXYL solution also contains hyaluronic acid (in the form of sodium hyaluronate), which protects and moisturizes the nasal mucosa.

RHINXYL solution is used for:

- reducing nasal mucosal congestion caused by inflammation of the nasal mucosa (rhinitis) or inflammation of the sinus mucosa (sinusitis).

Dosage and administration.

Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Talk to your doctor or pharmacist if you are not sure.

Dosage

Children aged between 2 and 12 years: 1 spray of RHINXYL HA 0.5 mg/ml nasal spray, solution in each nostril, up to 3 times a day. RHINXYL HA 0.5 mg/ml nasal spray, solution should not be used for more than 5 days, unless otherwise prescribed by a doctor.

Use can be repeated if treatment has been been interrupted for several days.

In case of chronic cold, the use of RHINXYL HA 0.5 mg/ml nasal spray, solution should be under medical supervision, to prevent atrophy (thinning) of the child's nasal mucosa.

Doses higher than the recommended doses should not be used.

Precautions.

Before using RHINXYL, talk to your doctor or pharmacist:

- if your child is being treated with monoamine oxidase inhibitors (MAOIs) (e.g., tranylcypromine and moclobemide, which are used for the treatment of depression) or has used MAOIs within the last 2 weeks, tricyclic or tetracyclic antidepressants, or other medicines that may increase blood pressure

- if your child is using medicines from the group of beta-blockers or alpha-blockers (frequently used to lower blood pressure or in the treatment of benign prostatic hypertrophy (enlargement))

Special warnings.

Pregnancy, breastfeeding and fertility

This concentration of RHINXYL HA 0.5 mg/ml nasal spray, solution is intended for use in children. However, this information is valid for the active substance, xylometazoline hydrochloride. If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. There are no adequate data on the use of xylometazoline hydrochloride in pregnant women. Therefore, RHINXYL HA 0.5 mg/ml nasal spray, solution should not be used during pregnancy. This medicine should not be used during breastfeeding, as it is not known whether xylometazoline hydrochloride is excreted in human milk.

Driving and using machines

No reduction in the ability to drive vehicles or use machines is expected if the medicine is used according to instructions.

Packaging. 10 ml of solution in a white plastic bottle, equipped with a dosing pump, with an applicator tip and a protective cap, packed in a box.

Page updated on: 08.06.2021